Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
about
Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial
description
article
@en
im Juli 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2018
@uk
ലേഖനം
@ml
name
Induction of Cross-Clade Antib ...... Virus Ankara-Based Influenza A
@nl
Induction of Cross-Clade Antib ...... ized Phase 1/2a Clinical Trial
@en
type
label
Induction of Cross-Clade Antib ...... Virus Ankara-Based Influenza A
@nl
Induction of Cross-Clade Antib ...... ized Phase 1/2a Clinical Trial
@en
altLabel
Induction of Cross-Clade Antib ...... ized Phase 1/2a Clinical Trial
@en
prefLabel
Induction of Cross-Clade Antib ...... Virus Ankara-Based Influenza A
@nl
Induction of Cross-Clade Antib ...... ized Phase 1/2a Clinical Trial
@en
P2093
P2860
P50
P356
P1476
Induction of Cross-Clade Antib ...... ized Phase 1/2a Clinical Trial
@en
P2093
Arwen F Altenburg
David F Nieuwenhuijse
Joost H C M Kreijtz
Mark R Pronk
Mart M Lamers
Nella J Nieuwkoop
Rory D de Vries
Stella E van Trierum
P2860
P304
P356
10.1093/INFDIS/JIY214
P407
P577
2018-07-13T00:00:00Z